계명대학교 의학도서관 Repository

변비 약물 치료의 지침 – 어떤 약제를, 언제 사용해야 하는가?

Metadata Downloads
Author(s)
신정은홍경섭정기욱이태희이봉은박선영홍성노김성은박경식최석채대한소화기기능성질환·운동학회 변비 및 항문직장기능 연구회
Keimyung Author(s)
Park, Kyung Sik
Department
Dept. of Internal Medicine (내과학)
Journal Title
대한내과학회지
Issued Date
2015
Volume
88
Issue
1
Abstract
To manage chronic constipation, dietary and lifestyle modifications should be tried before pharmacological intervention.
Although there is no standardized treatment guideline for medical practice, the key considerations in the choice of laxative include
the treatment duration, dosing schedule, type of agent, effects and side effects of the agent, and cost. The first-line treatment is a
bulking or osmotic laxative. If the patient is still symptomatic, the physician can add or switch to other laxatives. Next, prucalopride,
a highly selective 5-hydroxytryptamine 4 (5-HT4) receptor agonist, could be considered. If the constipation is refractory to
combination therapy with conventional laxatives and prucalopride, patients should be referred for further evaluation, including
physiological testing. (Korean J Med 2015;88:22-26)
Keywords: Constipation; Laxatives
Alternative Title
Guidelines for the Use of Laxatives - Which Laxatives, When?
Keimyung Author(s)(Kor)
박경식
Publisher
School of Medicine
Citation
신정은 et al. (2015). 변비 약물 치료의 지침 – 어떤 약제를, 언제 사용해야 하는가? 대한내과학회지, 88(1), 22–26. doi: 10.3904/kjm.2015.88.1.22
Type
Article
ISSN
1738-9364
DOI
10.3904/kjm.2015.88.1.22
URI
https://kumel.medlib.dsmc.or.kr/handle/2015.oak/37705
Appears in Collections:
1. School of Medicine (의과대학) > Dept. of Internal Medicine (내과학)
공개 및 라이선스
  • 공개 구분공개
파일 목록

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.